Skip to main content
Turkish Journal of Hematology logoLink to Turkish Journal of Hematology
. 2017 Mar 1;34(1):124–125. doi: 10.4274/tjh.2016.0258

Internuclear Bridging of Erythroid Precursors in the Peripheral Blood Smear of a Patient with Primary Myelofibrosis

Primer Miyelofibroz Tanılı Bir Hastanın Çevre Kanı Yaymasında Eritroid Öncüllerin Nükleuslar Arası Köprüleşmesi

Roger K Schindhelm 1,*, Marije M van Santen 2, Arie C van der Spek 3
PMCID: PMC5451683  PMID: 27658355

An 84-year-old male diagnosed with primary myelofibrosis based on WHO grade 2-3 fibrosis Figure 1 and the presence of the JAK2-V617F mutation was treated with supportive care. During 2 years of follow-up, his hemoglobin level was maintained at approximately 6.5 mmol/L and platelet count declined from 128x109/L at presentation to 50x109/L. White blood cells did not exceed 12.0x109/L, while the fraction of blast cells increased to 10%. Elevated levels of teardrop cells were observed and the nucleated red blood cell count gradually increased from non-detectable to 2.4x1012/L. Recent peripheral blood smears showed bi- and tri-nucleated red blood cells, and even more notably, erythroid precursors with internuclear chromatin and cytoplasmic bridging Figures 2 and 3. In concurrence with laboratory findings, physical examination revealed progressive splenomegaly (8 cm palpable below the rib margin) and weight loss. Erythroid precursors with internuclear bridging in a blood smear is a rare morphological finding and is considered a diagnostic morphologic feature in patients with congenital dyserythropoietic anemia type I and a morphological manifestation of dyserythropoiesis in patients with myelodysplastic syndrome [1, 2] In patients with myeloproliferative neoplasms, erythroid precursors’ internuclear bridging may indicate the transition to a more aggressive phase.

Figure 1. Bone marrow biopsy showing marked increase in reticulin fibers, especially in the areas of megakaryocyte clustering (Gomori, 10x).

Figure 1

Figure 2. Blood smear demonstrating teardrop cells, erythroid precursor with internuclear bridging, and one blast cell (May-Grünwald-Giemsa, 50x).

Figure 2

Figure 3. Blood smear demonstrating erythroid precursor with internuclear and cytoplasmic bridging (May-Grünwald-Giemsa, 100x).

Figure 3

Footnotes

Conflict of Interest: The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.

References

  • 1.Iolascon A, Esposito MR, Russo R. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach. Haematologica. 2012;97:1786–1794. doi: 10.3324/haematol.2012.072207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Head DR, Kopecky K, Bennett JM, Grenier K, Morrison FS, Miller KB, Grever MR. Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative Study. Cancer. 1989;64:2199–2202. doi: 10.1002/1097-0142(19891201)64:11<2199::aid-cncr2820641102>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]

Articles from Turkish Journal of Hematology are provided here courtesy of Galenos Yayinevi

RESOURCES